There is a paucity of literature regarding the daily routines of young children (4-7 years) and their perception of their performance. Research indicates that children's involvement in treatment therapy improves their self-consciousness, which contributes in return to the therapy's progress. Until recently, occupational therapists set goals for children by involving their parents in the planning. However, recent studies indicate that children are aware of their performance and can provide reliable data, given an evaluation that is adapted to their stage of development. "Make My Day" (MMD) is a new evaluation developed for young children, which provides information regarding the child's performance with respect to their daily activities. The MMD incorporates two versions--one for the children's self-report and the other for the parent's report. Participants included 62 healthy 4- to 7-year-old children of Arab-Israeli decent and their parents. They were assessed using the MMD, Perceived Efficacy and Goal Setting (PEGS), Time Organization and Participation (TOPS) and a socio-demographic questionnaire. Correlations between the MMD and the TOPS/PEGS were examined regarding the differences between children's and parents' reports of performance in three age groups (concurrent validity). Results demonstrated that children's self-report of their occupational performance in daily tasks are reliable and valid. Thus, occupational therapists may obtain data from the child himself or herself and not only from the parents. Further research on the MMD is recommended in other clinical populations to increase our knowledge of their daily functioning and of MMD's validity.

Download full-text PDF

Source
http://dx.doi.org/10.1002/oti.1350DOI Listing

Publication Analysis

Top Keywords

daily activities
8
young children
8
occupational therapists
8
children's self-report
8
children's
5
daily
5
children
5
performance
5
mmd
5
establishing reliability
4

Similar Publications

Evaluating the Real-World Safety of Icosapent Ethyl Versus Omega-3 Polyunsaturated Fatty Acid in Nationwide US Veterans Cohort: Examining Atrial Fibrillation and Bleeding Endpoints.

Clin Drug Investig

January 2025

Department of Medicine, Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Perelman School of Medicine, 423 Guardian Drive, Philadelphia, PA, 19104, USA.

Purpose: The REDUCE-IT randomized trial demonstrated a cardiovascular benefit of icosapent ethyl (IPE) but also raised potential safety signals for atrial fibrillation (AF) and serious bleeding. We aimed to evaluate the real-world safety of IPE versus mixed omega-3 polyunsaturated fatty acid (OM-3) formulations.

Methods: This retrospective active comparator new-user cohort study compared rates of new-onset AF and major bleeding (MB) among adult new users of IPE versus OM-3 in 2020-2024 US Veterans Affairs data.

View Article and Find Full Text PDF

Objectives: Gastrointestinal (GI) disturbance is a frequent complication in patients with thoracolumbar vertebral fracture (TVF). Transcutaneous electrical acustimulation (TEA) has been reported to effectively accelerate postoperative GI function recovery after abdominal surgery. This study aimed to investigate the effects of TEA on postoperative recovery and the associated mechanisms.

View Article and Find Full Text PDF

The wheelchair service delivery process (SDP) is a large complex system and therefore has many potential points of failure; determining priorities for improvement is challenging. The complexities introduce several barriers to accessing and maintaining wheelchairs for individuals with mobility impairments. Given the breadth and depth of the barriers, it is important to know in which areas to focus future policy reform efforts.

View Article and Find Full Text PDF

Background: Arthroscopic labral repair of the hip is successfully performed with increasing frequency using either knotless or knotted suture anchors, each with its own risks and benefits.

Purpose: To examine biomechanical and clinical outcomes for labral repair of the hip based on the use of knotted or knotless suture anchors.

Study Design: Systematic review; Level of evidence, 4.

View Article and Find Full Text PDF

NIM-1324 is an oral investigational new drug for autoimmune disease that targets the Lanthionine Synthetase C-like 2 (LANCL2) pathway. Through activation of LANCL2, NIM-1324 modulates CD4+ T cells to bias signaling and cellular metabolism toward increased immunoregulatory function while providing similar support to phagocytes. In primary human immune cells, NIM-1324 reduces type I interferon and inflammatory cytokine (IL-6, IL-8) production.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!